🇪🇺 Tybost in European Union

EMA authorised Tybost on 19 September 2013

Marketing authorisation

EMA — authorised 19 September 2013

  • Marketing authorisation holder: Gilead Sciences Ireland UC
  • Status: approved

Tybost in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in European Union

Frequently asked questions

Is Tybost approved in European Union?

Yes. EMA authorised it on 19 September 2013.

Who is the marketing authorisation holder for Tybost in European Union?

Gilead Sciences Ireland UC holds the EU marketing authorisation.